| Salmon River Chiropractic Inc. | |
|
104 S Daisy St, Suite A, Salmon, ID 83467-4333 | |
| (208) 756-5000 | |
| Not Available |
| Full Name | Salmon River Chiropractic Inc. |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 104 S Daisy St, Salmon, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225068059 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | CHIA-1182 (Idaho) | Primary |
| Provider Name | Lance S Ingwersen |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1295766822 PECOS PAC ID: 7810990355 Enrollment ID: I20060822000626 |
News Archive
Univfy, a pioneer in the development of personalized in vitro fertilization (IVF) prognostic tools, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by its founding scientific team and clinical collaborators from Stanford University.
An FDA panel of oncologists has voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients. Xgeva is already approved to prevent fractures in cancerous bones, and for osteoporosis, in a different formulation called Prolia.
Apria Healthcare Group Inc. (the "Issuer") announced today that it is commencing exchange offers for all of its outstanding 11.25% Senior Secured Notes due 2014 (Series A-1) (the "Outstanding Series A-1 Notes") and 12.375% Senior Secured Notes due 2014 (Series A-2) (the "Outstanding Series A-2 Notes" and, together with Outstanding Series A-1 Notes, the "Outstanding Notes"), upon the terms and conditions set forth in a prospectus, dated August 16, 2010, and in the accompanying letter of transmittal relating to the exchange offers.
A Mayo Clinic research team has challenged the accepted theory on the cause of sepsis - a condition in which the body's cells generate fever, shock and often death. Sepsis is thought to occur when poisons from bacterial infection interfere with the cells.
Arrayit Corporation today announced the sale of a system to the Center of Excellence for Nucleic Acid-Based Technologies (CENAT) in Poznan, Poland. The Arrayit NanoPrint Microarrayer will be used by CENAT for scientific and medical collaborations throughout the prosperous democracy.
› Verified 7 days ago
| Provider Name | Jennifer V Coffey |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1891726196 PECOS PAC ID: 6901809441 Enrollment ID: I20070308000661 |
News Archive
Univfy, a pioneer in the development of personalized in vitro fertilization (IVF) prognostic tools, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by its founding scientific team and clinical collaborators from Stanford University.
An FDA panel of oncologists has voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients. Xgeva is already approved to prevent fractures in cancerous bones, and for osteoporosis, in a different formulation called Prolia.
Apria Healthcare Group Inc. (the "Issuer") announced today that it is commencing exchange offers for all of its outstanding 11.25% Senior Secured Notes due 2014 (Series A-1) (the "Outstanding Series A-1 Notes") and 12.375% Senior Secured Notes due 2014 (Series A-2) (the "Outstanding Series A-2 Notes" and, together with Outstanding Series A-1 Notes, the "Outstanding Notes"), upon the terms and conditions set forth in a prospectus, dated August 16, 2010, and in the accompanying letter of transmittal relating to the exchange offers.
A Mayo Clinic research team has challenged the accepted theory on the cause of sepsis - a condition in which the body's cells generate fever, shock and often death. Sepsis is thought to occur when poisons from bacterial infection interfere with the cells.
Arrayit Corporation today announced the sale of a system to the Center of Excellence for Nucleic Acid-Based Technologies (CENAT) in Poznan, Poland. The Arrayit NanoPrint Microarrayer will be used by CENAT for scientific and medical collaborations throughout the prosperous democracy.
› Verified 7 days ago
| Provider Name | Alicia S Hanford |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1639893464 PECOS PAC ID: 4385016229 Enrollment ID: I20230202001321 |
News Archive
Univfy, a pioneer in the development of personalized in vitro fertilization (IVF) prognostic tools, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by its founding scientific team and clinical collaborators from Stanford University.
An FDA panel of oncologists has voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients. Xgeva is already approved to prevent fractures in cancerous bones, and for osteoporosis, in a different formulation called Prolia.
Apria Healthcare Group Inc. (the "Issuer") announced today that it is commencing exchange offers for all of its outstanding 11.25% Senior Secured Notes due 2014 (Series A-1) (the "Outstanding Series A-1 Notes") and 12.375% Senior Secured Notes due 2014 (Series A-2) (the "Outstanding Series A-2 Notes" and, together with Outstanding Series A-1 Notes, the "Outstanding Notes"), upon the terms and conditions set forth in a prospectus, dated August 16, 2010, and in the accompanying letter of transmittal relating to the exchange offers.
A Mayo Clinic research team has challenged the accepted theory on the cause of sepsis - a condition in which the body's cells generate fever, shock and often death. Sepsis is thought to occur when poisons from bacterial infection interfere with the cells.
Arrayit Corporation today announced the sale of a system to the Center of Excellence for Nucleic Acid-Based Technologies (CENAT) in Poznan, Poland. The Arrayit NanoPrint Microarrayer will be used by CENAT for scientific and medical collaborations throughout the prosperous democracy.
› Verified 7 days ago
| Provider Name | Mark A Kennington |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1417618596 PECOS PAC ID: 1052779337 Enrollment ID: I20230619000525 |
News Archive
Univfy, a pioneer in the development of personalized in vitro fertilization (IVF) prognostic tools, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by its founding scientific team and clinical collaborators from Stanford University.
An FDA panel of oncologists has voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients. Xgeva is already approved to prevent fractures in cancerous bones, and for osteoporosis, in a different formulation called Prolia.
Apria Healthcare Group Inc. (the "Issuer") announced today that it is commencing exchange offers for all of its outstanding 11.25% Senior Secured Notes due 2014 (Series A-1) (the "Outstanding Series A-1 Notes") and 12.375% Senior Secured Notes due 2014 (Series A-2) (the "Outstanding Series A-2 Notes" and, together with Outstanding Series A-1 Notes, the "Outstanding Notes"), upon the terms and conditions set forth in a prospectus, dated August 16, 2010, and in the accompanying letter of transmittal relating to the exchange offers.
A Mayo Clinic research team has challenged the accepted theory on the cause of sepsis - a condition in which the body's cells generate fever, shock and often death. Sepsis is thought to occur when poisons from bacterial infection interfere with the cells.
Arrayit Corporation today announced the sale of a system to the Center of Excellence for Nucleic Acid-Based Technologies (CENAT) in Poznan, Poland. The Arrayit NanoPrint Microarrayer will be used by CENAT for scientific and medical collaborations throughout the prosperous democracy.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Salmon River Chiropractic Inc. 104 S Daisy St, Suite A, Salmon, ID 83467-4333 Ph: (208) 756-5000 | Salmon River Chiropractic Inc. 104 S Daisy St, Suite A, Salmon, ID 83467-4333 Ph: (208) 756-5000 |
News Archive
Univfy, a pioneer in the development of personalized in vitro fertilization (IVF) prognostic tools, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by its founding scientific team and clinical collaborators from Stanford University.
An FDA panel of oncologists has voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients. Xgeva is already approved to prevent fractures in cancerous bones, and for osteoporosis, in a different formulation called Prolia.
Apria Healthcare Group Inc. (the "Issuer") announced today that it is commencing exchange offers for all of its outstanding 11.25% Senior Secured Notes due 2014 (Series A-1) (the "Outstanding Series A-1 Notes") and 12.375% Senior Secured Notes due 2014 (Series A-2) (the "Outstanding Series A-2 Notes" and, together with Outstanding Series A-1 Notes, the "Outstanding Notes"), upon the terms and conditions set forth in a prospectus, dated August 16, 2010, and in the accompanying letter of transmittal relating to the exchange offers.
A Mayo Clinic research team has challenged the accepted theory on the cause of sepsis - a condition in which the body's cells generate fever, shock and often death. Sepsis is thought to occur when poisons from bacterial infection interfere with the cells.
Arrayit Corporation today announced the sale of a system to the Center of Excellence for Nucleic Acid-Based Technologies (CENAT) in Poznan, Poland. The Arrayit NanoPrint Microarrayer will be used by CENAT for scientific and medical collaborations throughout the prosperous democracy.
› Verified 7 days ago
Karli Keys, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1911 Main St, Salmon, ID 83467 Phone: 208-756-2211 | |
Dr. Lance Shane Ingwersen, D.C Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 104 S Daisy St, Suite A, Salmon, ID 83467 Phone: 208-756-5000 | |
Mark A Kennington, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 104 S Daisy St # A, Salmon, ID 83467 Phone: 208-756-2202 Fax: 208-756-2213 | |
Bradley Marx, Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 104 S Daisy St Ste A, Salmon, ID 83467 Phone: 208-756-2202 | |
Mr. Brian A Barry, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 818 Main St, Suite F, Salmon, ID 83467 Phone: 208-756-1428 | |
Alicia Hanford, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 104 S Daisy St Ste A, Salmon, ID 83467 Phone: 208-756-2202 |